Novel Antimalarial Drug Targets
SAM.GOV Due: June 2, 2025 at 02:00 PM UTC
In-Active Special Notice Source Url

Summary

The opportunity titled 'Novel Antimalarial Drug Targets' is a special notice issued by the United States Army Medical Research Acquisition Activity (USAMRAA) to negotiate on a sole source basis with Portland State University (PSU). This initiative aims to support the investigation of novel antimalarial drug targets through affinity-based pulldowns, requiring specialized chemistry expertise in the structure-activity relationship (SAR) of compound WR936909. The selected contractor will be responsible for testing compounds and chemical probes in the Plasmodium asexual blood-stage assay before advancing to the Plasmodium liver-stage model. Businesses with a strong background in infectious disease research, particularly in malaria, and those capable of conducting advanced chemical profiling and testing are encouraged to consider bidding on this opportunity.
Description

Place of Performance: Contractor Facility

The United States Army Medical Research Acquisition Activity (USAMRAA) intends to negotiate on a sole source basis IAW FAR 13.5 to Portland State University (PSU) 1600 SW 4th Ave. Portland, OR 97201 as the only responsible source that can provide

Entities
DOD
Department of Defense
DHA(
Defense Health Agency
NAICS
541714
Set Aside
None
Place of Performance
Point of Contact
Full Name Email Phone Type
Jaclyn Svincek [email protected] 3016192189 primary
Jennifer Jackson [email protected] secondary